BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34062582)

  • 1. [Hormonal contraception and venous thromboembolism].
    Hart C; Linnemann B
    Dtsch Med Wochenschr; 2021 Jun; 146(11):705-709. PubMed ID: 34062582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex matters: Practice 5P's when treating young women with venous thromboembolism.
    Bistervels IM; Scheres LJJ; Hamulyák EN; Middeldorp S
    J Thromb Haemost; 2019 Sep; 17(9):1417-1429. PubMed ID: 31220399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
    Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism in women: a specific reproductive health risk.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2013; 19(5):471-82. PubMed ID: 23825156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Birth Control Pills and Thrombotic Risks: Differences of Contraception Methods with and without Estrogen.
    Rott H
    Hamostaseologie; 2019 Feb; 39(1):42-48. PubMed ID: 30669160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous Thromboembolism Issues in Women.
    Linnemann B; Rott H; Zotz R; Hart C
    Hamostaseologie; 2022 Oct; 42(5):290-299. PubMed ID: 36323276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.
    Wu O; Robertson L; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Langhorne P; Brenkel I; Regan L; Greer I
    Health Technol Assess; 2006 Apr; 10(11):1-110. PubMed ID: 16595080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex hormones and venous thromboembolism - from contraception to hormone replacement therapy.
    Beyer-Westendorf J; Bauersachs R; Hach-Wunderle V; Zotz RB; Rott H
    Vasa; 2018 Oct; 47(6):441-450. PubMed ID: 30008249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of recurrent venous thromboembolism among young women after a first event while exposed to combined oral contraception versus not exposed to: a cohort study.
    Le Moigne E; Delluc A; Tromeur C; Nowak E; Mottier D; Lacut K; Le Gal G
    Thromb Res; 2013 Jul; 132(1):51-5. PubMed ID: 23786893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hormonal contraception and vascular risk: CNGOF Contraception Guidelines].
    Plu-Bureau G; Sabbagh E; Hugon-Rodin J
    Gynecol Obstet Fertil Senol; 2018 Dec; 46(12):823-833. PubMed ID: 30389542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contraception-related venous thromboembolism in adolescents.
    O'Brien SH
    Semin Thromb Hemost; 2014 Feb; 40(1):66-71. PubMed ID: 24356931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progestin-only contraception and thromboembolism: A systematic review.
    Tepper NK; Whiteman MK; Marchbanks PA; James AH; Curtis KM
    Contraception; 2016 Dec; 94(6):678-700. PubMed ID: 27153743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal management of hormonal contraceptives after an episode of venous thromboembolism.
    Klok FA; Barco S
    Thromb Res; 2019 Sep; 181 Suppl 1():S1-S5. PubMed ID: 31477219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study.
    Le Gal G; Kovacs MJ; Carrier M; Do K; Kahn SR; Wells PS; Anderson DA; Chagnon I; Solymoss S; Crowther M; Righini M; Lacut K; White RH; Vickars L; Rodger M
    Thromb Haemost; 2010 Sep; 104(3):498-503. PubMed ID: 20539910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thromboembolism in pregnancy: diagnosis, management and prevention.
    Chunilal SD; Bates SM
    Thromb Haemost; 2009 Mar; 101(3):428-38. PubMed ID: 19277402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type of Combined Contraceptives, Factor V Leiden Mutation and Risk of Venous Thromboembolism.
    Hugon-Rodin J; Horellou MH; Conard J; Gompel A; Plu-Bureau G
    Thromb Haemost; 2018 May; 118(5):922-928. PubMed ID: 29614525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism associated with pregnancy and hormonal therapy.
    Jacobsen AF; Sandset PM
    Best Pract Res Clin Haematol; 2012 Sep; 25(3):319-32. PubMed ID: 22959548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Contraception in Adolescent Females With Hormone-Related Venous Thromboembolism.
    Maher KN; Quint EH; Weyand AC
    J Adolesc Health; 2022 Jul; 71(1):127-131. PubMed ID: 35428559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary prevention of VTE spans a spectrum.
    Arnold MJ; Smith DK
    J Fam Pract; 2020 Oct; 69(8):386;388;390;395. PubMed ID: 33175919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolism and women's health.
    Speed V; Roberts LN; Patel JP; Arya R
    Br J Haematol; 2018 Nov; 183(3):346-363. PubMed ID: 30334572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.